SCHEMBL23959002

SCHEMBL23959002

C=C(F)/C(=N\C)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.44
CES1 P23141 2/20 0.44
SRD5A2 P31213 1/20 0.39
NR4A1 P22736 1/20 0.39
NR4A2 P43354 1/20 0.39
NR4A3 Q92570 1/20 0.39
GSK3B P49841 2/20 0.38
PTPN1 P18031 2/20 0.38
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
PTGS1 P23219 2/20 0.37
NQO2 P16083 1/20 0.37
PTGS2 P35354 1/20 0.37
PAX8 Q06710 1/20 0.37
TRPV1 Q8NER1 1/20 0.37
HTR3E A5X5Y0 1/20 0.36
HTR3B O95264 1/20 0.36
PLAU P00749 1/20 0.36
HTR3A P46098 1/20 0.36
HTR3D Q70Z44 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23958719 0.79 CES2 (0.38) CES2CES1NOS3NOS1
SCHEMBL23958880 0.72 CES2 (0.45) CES2CES1PTGS2
SCHEMBL1474670 0.71 CES2 (0.54) CES2CES1SRD5A2NR4A1NR4A2
SCHEMBL27472277 0.71 CES2 (0.72) CES2CES1SRD5A2NR4A1NR4A2
SCHEMBL28243558 0.71 CES2 (0.58) CES2CES1SRD5A2NR4A1NR4A2
SCHEMBL28402017 0.69 CES2 (0.56) CES2CES1SRD5A2NR4A1NR4A2
SCHEMBL18348347 0.68 CES2 (0.50) CES2CES1SRD5A2NR4A1NR4A2
SCHEMBL17288598 0.68 CES2 (0.61) CES2CES1SRD5A2NR4A1NR4A2
SCHEMBL11876853 0.68 CES2 (0.45) CES2CES1SRD5A2NR4A1NR4A2
SCHEMBL11876849 0.68 CES2 (0.45) CES2CES1SRD5A2NR4A1NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021214136-A1 RSV INHIBITING 3-SUBSTITUTED QUINOLINE AND CINNOLINE DERIVATIVES Janssen Sciences Ireland Unlimited Company (IE) 2021-10-28 WO disclosed